Editorial introductions

Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor and Section Editors for this issue. EDITOR Robert A HegeleRobert A HegeleRob Hegele is a distinguished University Professor of Medicine and Biochemistry, University of Western Ontario, Canada, and Director of the Lipid Genetics Clinic and the London Regional Genomics Centre in London, Ontario, Canada. He received his MD degree from the University of Toronto in 1981. His specialty training in internal medicine and in endocrinology & metabolism was also in Toronto. His post-doctoral research fellowships were at Rockefeller University, USA, and Howard Hughes Medical Institute, University of Utah, USA. From 1989 to 1997 he was on the Faculty of Medicine at the University of Toronto. In 1997 Dr Hegele joined the Schulich School of Medicine and Dentistry and the Robarts Research Institute at the Western University, in London, Ontario, Canada, where he holds the Jacob J. Wolfe Distinguished Medical Research Chair and the Martha Blackburn Chair in Cardiovascular Research. His lab studies the genetics of lipoprotein metabolism, cardio¬vascular disease and diabetes mellitus. Solely or through collaborations, his lab was first to describe the molecular genetic basis of 20 human diseases. His lab has also defined much of the genetic basis of complex disorders, including hypertriglyceridemia. He has co-authored over 600 peer-reviewed publications and has contributed to national treatment guidelines for dyslipidemia, hypertension and diabetes. He is a practicing endocrinologist and has participated in numerous clinical trials. He has trained numerous physicians and graduate students. SECTION EDITORS Majken K. JensenMajken K. Jensen, PhD, is Associate Professor of Nutrition and Epidemiology at Harvard T. H. Chan School of Public Health. Dr Jensen's primary research interests include novel metabolic markers, nutrition, and genetics, in relation to chronic lifestyle diseases. In ongoing collaborations with Dr Frank Sacks, they investigate how the presence of a small proinflammatory protein (apolipoprotein C-III) on HDL particles marks a potentially dysfunctional type of HDL that is not inversely associated with risk of cardiometabolic health, such as IMT, diabetes and cardiovascular disease. Other currently funded work is focused on lipoprotein metabolism and Alzheimer's disease and stroke. Her research predominantly utilizes large-scale observational studies (including the Health Professionals Follow-Up Study, the Nurses’ Health Study, the Danish Diet, Cancer and Health study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study) where cost-efficient prospective case-control studies are nested within for purpose of measuring novel biomarkers or genome-wide markers. Dr Jensen's research has been published in leading scientific journals and has been recognized with numerous awards. She received the Trudy Bush Fellowship for Cardiovascular Disease Research in Women's Health from the American Heart Association in 2011 and originally came for research studies at Harvard T. H. Chan School of Public Health as a Fulbright scholar. Dr Jensen has published over 80 original research articles and 5 reviews, editorials, and letters. Marta Guasch-FerréMarta Guasch-FerréDr. Guasch-Ferré is an Associate Professor and Group Leader at the Department of Public Health and Novo Nordisk Center for Basic Metabolic Research at the University of Copenhagen, Denmark. She also holds an appointment as Adjunct Associate Professor at the Department of Nutrition at Harvard T.H. Chan School of Public Health, U.S. Her research focuses on nutritional and lifestyle epidemiology and prevention of type 2 diabetes (T2D) and cardiovascular disease (CVD). She has incorporated high-throughput –omics techniques, particularly metabolomics, into traditional epidemiological analysis to gain insights into underlying mechanisms that could explain the associations between lifestyle factors in relation to CVD and T2D. She has been involved in the design and implementation of several clinical trials including the well-known PREDIMED trial, a primary cardiovascular prevention trial. She currently works on large prospective cohort studies on the Nurses’ Health Study and the Health Professional's Follow-up Study. Her research activities have resulted in numerous manuscripts (>130, H-index 43), and she has been awarded with various competitive European and American grants. Dr. Guasch-Ferré was the recipient of the Sandra A. Daugherty Award for Excellence in Cardiovascular Disease or Hypertension Epidemiology and Prevention by the American Heart Association (2021). She serves as the P.I. of a NIH-funded project entitled ‘Circulating plasma metabolites, lifestyle factors, and mortality risk’. She is also an investigator in two NIH-funded projects to study Mediterranean dietary interventions, plasma metabolites, and the risk of CVD and T2D.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.